Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02354326 · ClinicalTrials.gov registry record
Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 16
- Enrollment target
NCT02354326: Clinical Trial study, sponsored by Case Comprehensive Cancer Center.
NCT02354326 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02354326 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This clinical trial studies dual energy computed tomography (CT) in finding cancer that has spread from the original (primary) tumor to the bone (bone metastases) in patients with cancer. Diagnostic procedures, such as dual energy CT, may help find and diagnose bone metastases and may be more accurate compared to single energy CT alone.
Primary Outcome
Number of lesions detected at the 46 designated locations at the time of the VNC DECT
Interventions
- RADIATION virtual non-calcium dual-energy computed tomography
- RADIATION computed tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-11-07 |
| Est. Completion | 2017-09-27 |
Why NCT02354326 stopped before completion
NCT02354326 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which virtual non-calcium dual-energy computed tomography is the first listed.
NCT02354326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02354326 about?
NCT02354326 is a clinical study titled "Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer". This clinical trial studies dual energy computed tomography (CT) in finding cancer that has spread from the original (primary) tumor to the bone (bone metastases) in patients with cancer. Diagnostic procedures, such as dual energy CT, may help find and diagnose bone metastases and may be more accura...
What is the current status of trial NCT02354326?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2014-11-07. Estimated completion is 2017-09-27.
What interventions are being tested in trial NCT02354326?
The interventions under investigation include: virtual non-calcium dual-energy computed tomography (RADIATION), computed tomography (RADIATION).
Who is sponsoring clinical trial NCT02354326?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI